Harlinde Peperstraete: From Circuit to Coagulation – Understanding Hemostasis in ECMO
Harlinde Peperstraete, Adjunct Kliniekhoofd at University Hospital Ghent, shared a post on LinkedIn about a recent article by she and her colleagues co-authored, published in Critical Care, adding:
“Very happy and proud to share our latest publication in Critical Care:
‘Extracorporeal life support and Modification Of Hemostasis:
the ELMOH trial:
hemostatic changes during the first 48 h of VV- and VAECMO: a prospective multicenter cohort study’
‘The hemostatic story starts before the circuit does.’
In this prospective multicenter cohort study, we explored hemostatic changes before and during the first 48 hours of VV- and VA-ECMO.
One of the key findings was that patients supported for circulatory failure and those supported for isolated respiratory failure already showed different hemostatic profiles at baseline.
VA-ECMO patients had lower platelet counts and a more hypocoagulable profile early on, while VV-ECMO patients remained relatively hypercoagulable during the first 48 hours.
These findings suggest that early coagulation abnormalities in ECMO patients reflect both the underlying clinical condition and the effects of extracorporeal support.
They support the need for individualized hemostatic monitoring and anticoagulation management.
A heartfelt thank you to my co-authors and collaborators for their dedication, insight, and teamwork:
Harlinde Peperstraete, Korneel Vandewiele, Katrien M. J. Devreese, Paul Massion, Michael Piagnerelli, Matthias Raes, Pieter Depuydt, and Eric Hoste.
This work would not have been possible without the ICU teams, study coordinators, and participating centers involved in patient inclusion, sampling, and data collection.
Because in ECMO, balancing bleeding and thrombosis is never routine, it is personal.”
Title: ExtracorporeaL life support and Modification Of Hemostasis: the ELMOH trial: hemostatic changes during the first 48 h of VV- and VA-ECMO: a prospective multicenter cohort study
Authors: Harlinde Peperstraete, Korneel Vandewiele, Katrien M. J. Devreese, Paul Massion, Michaël Piagnerelli, Matthias Raes, Pieter Depuydt and Eric Hoste
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 21:47Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention
-
Sep 29, 2026, 22:26A Global Call for Action on Cardiovascular Health on World Heart Day – ISTH